Dr Jim Miller joins Insmed
This article was originally published in Scrip
Insmed (US) has named Dr Jim Miller vice-president of process development. He will help in the development of Insmed Therapeutic Proteins' portfolio of follow-on biologics. Dr Miller has more than 25 years' experience in biopharmaceutical product research and preclinical development; he previously served as executive vice-president of product development at Saronyx, a private life sciences company that he also co-founded.